Intravenous Solutions Market Size, Share & Trends Analysis Report By Type (Total Parenteral Nutrition, Peripheral Parenteral Nutrition), By Nutrients (Carbohydrates, Vitamins & Minerals, Single-dose Amino Acids), By End Use, By Region, And Segment Forecas

Intravenous Solutions Market Summary

The global intravenous solutions market size was valued at USD 12.80 billion in 2024 and is expected to reach USD 28.2 billion by 2033, growing at a CAGR of 9.4% from 2025 to 2033. This growth is attributed to the increasing prevalence of diseases, such as neurological diseases, gastrointestinal diseases, and cancer.

IV solutions provide essential nutrients and are a main source of energy. The rising rates of premature births in developed countries such as the U.S. and the UK are further fueling the demand for intravenous (IV) solutions, as these nations have advanced neonatal care infrastructure that relies heavily on IV therapy. In these countries, factors such as increasing maternal age, higher rates of assisted reproductive technologies (ART), and chronic maternal conditions such as diabetes and hypertension have contributed to a growing number of preterm deliveries. For instance, according to Tommy's, the premature birth rate in England and Wales rose to 7.9% in 2022, up from 7.5% in 2021, marking two consecutive years of increase. Over 53,000 babies were born prematurely in 2022.

To learn more about this report, Download Free Sample Report

The table below shows the percent distribution of singleton births, by gestational age: U.S., 2014 - 2022.

Malnutrition is one of the major drivers of the Intravenous (IV) solution market. According to the WHO, in 2022, 2.5 billion adults were overweight, with 890 million living with obesity, while 390 million were underweight. Globally, 149 million children under 5 were stunted, 45 million were wasted, and 37 million were overweight or obese. This high prevalence of malnutrition globally contributes to market growth. According to UNICEF, poor nutrition in the first 1,000 days of an infant’s life may lead to impaired cognitive ability and stunted growth. Starch, minerals, vitamins, amino acids, lipids, and other key substances must be present in an infant’s diet. These essential nutrients can be administered through parenteral nutrition, which is expected to boost the market. A high number of malnourished children and premature neonates that require these nutrients is expected to further propel the market.

Global Intravenous Solutions Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global intravenous solutions market report based on type, nutrient, end use and regions:

• Type Outlook (Revenue, USD Million, 2021 - 2033)
• Total Parenteral Nutrition
• Peripheral Parenteral Nutrition
• Nutrients Outlook (Revenue, USD Million, 2021 - 2033)
• Carbohydrates
• Vitamins & Minerals
• Single-dose Amino Acids
• Parenteral Lipid Emulsion
• Others
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Home
• Hospitals
• Infusion Centers
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
• U.S.
• Canada
• Mexico
• Europe
• UK
• Germany
• France
• Italy
• Spain
• Denmark
• Sweden
• Norway
• Asia Pacific
• China
• Japan
• India
• South Korea
• Australia
• Thailand
• Latin America
• Brazil
• Argentina
• Middle East and Africa (MEA)
• South Africa
• Saudi Arabia
• UAE
• Kuwait

Please note The report will be delivered in 2-3 business days upon order notification. Show more